CV Sciences, Inc.
CVSI · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $7,739 | $6,818 | $5,970 | $6,228 |
| - Cash | $381 | $886 | $812 | $454 |
| + Debt | $860 | $1,492 | $1,523 | $779 |
| Enterprise Value | $8,218 | $7,424 | $6,681 | $6,553 |
| Revenue | $0 | $3,620 | $3,606 | $3,884 |
| % Growth | -100% | 0.4% | -7.2% | – |
| Gross Profit | $1,579 | $1,844 | $1,658 | $1,677 |
| % Margin | – | 50.9% | 46% | 43.2% |
| EBITDA | -$275 | -$73 | $93 | -$618 |
| % Margin | – | -2% | 2.6% | -15.9% |
| Net Income | -$382 | -$261 | -$109 | -$726 |
| % Margin | – | -7.2% | -3% | -18.7% |
| EPS Diluted | -0.002 | -0.001 | -0.001 | -0.004 |
| % Growth | -50% | -133.3% | 84.6% | – |
| Operating Cash Flow | $0 | $287 | -$81 | -$164 |
| Capital Expenditures | $0 | -$49 | -$40 | -$18 |
| Free Cash Flow | $0 | $238 | -$121 | -$182 |